Adhesives Research to Present Hydrophilic Adhesive Technologies
|
By LabMedica International staff writers Posted on 03 Aug 2016 |

Image: Hydrophilic technologies for microfluidic devices (Photo courtesy of Adhesives Research).
Adhesives Research (AR; Glen Rock, PA, USA), a leading developer and manufacturer of high-performance pressure-sensitive adhesives, tapes, specialty coatings, films, and laminates, will hold a presentation at AACC 2016 on the range of opportunities for hydrophilic adhesive technologies, which are expanding as demand for microfluidic biological tests increases. They will also be presenting a range of custom tailored products, from devices that detect infectious diseases to test kits that monitor diabetes and blood coagulation.
Hydrophilic adhesive technologies reduce the surface tension of fluids, such as water, urine, or blood to allow for rapid flow from the inlet area to a remote reagent site within in vitro diagnostic (IVD) and microfluidic devices. Available as pressure-sensitive adhesives (PSAs), heat-seals, and coatings, the technology is compatible with sensitive chemistries, demonstrates strong bonding to low-surface energy plastics, provides tailorable hydrophilic properties to regulate capillary fill time, and can be customized by modifying thickness, choice of substrate, and release liner.
“Hydrophilic technology continues to be used in a variety of medical devices, including blood glucose and blood coagulation point-of-care, in-house, and environmental test kits,” said Herb Hand, a senior scientist with over 24 years pioneering research on hydrophilic adhesives and coatings at AR, who will lead the discussion. “The future of hydrophilic tapes includes components in molecular diagnostic devices and devices for the discovery of infectious diseases.”
AR leverages core competencies in chemical synthesis formulation and coating technologies to provide a gamut of custom tailored products for diverse applications around the world in the construction, industrial, electronics, automotive, medical, and pharmaceutical industries. AR also operates manufacturing facilities in Ireland and Colombia; has sales and marketing offices in Great Britain, Singapore and China; and sales representation in Japan and Taiwan.
The American Association for Clinical Chemistry (AACC; Washington, DC, USA) is an international scientific/medical society of over 8,000 clinical laboratory professionals, physicians, research scientists and more. The AACC annual meeting, which will be held from July 31st to August 4th at the Pennsylvania Convention Center in Philadelphia (USA), features five days of educational sessions on scientific, clinical, technical and management challenges facing laboratory professionals, as well as the world’s largest Clinical Lab Expo.
Related Links:
Adhesives Research
American Association for Clinical Chemistry
Hydrophilic adhesive technologies reduce the surface tension of fluids, such as water, urine, or blood to allow for rapid flow from the inlet area to a remote reagent site within in vitro diagnostic (IVD) and microfluidic devices. Available as pressure-sensitive adhesives (PSAs), heat-seals, and coatings, the technology is compatible with sensitive chemistries, demonstrates strong bonding to low-surface energy plastics, provides tailorable hydrophilic properties to regulate capillary fill time, and can be customized by modifying thickness, choice of substrate, and release liner.
“Hydrophilic technology continues to be used in a variety of medical devices, including blood glucose and blood coagulation point-of-care, in-house, and environmental test kits,” said Herb Hand, a senior scientist with over 24 years pioneering research on hydrophilic adhesives and coatings at AR, who will lead the discussion. “The future of hydrophilic tapes includes components in molecular diagnostic devices and devices for the discovery of infectious diseases.”
AR leverages core competencies in chemical synthesis formulation and coating technologies to provide a gamut of custom tailored products for diverse applications around the world in the construction, industrial, electronics, automotive, medical, and pharmaceutical industries. AR also operates manufacturing facilities in Ireland and Colombia; has sales and marketing offices in Great Britain, Singapore and China; and sales representation in Japan and Taiwan.
The American Association for Clinical Chemistry (AACC; Washington, DC, USA) is an international scientific/medical society of over 8,000 clinical laboratory professionals, physicians, research scientists and more. The AACC annual meeting, which will be held from July 31st to August 4th at the Pennsylvania Convention Center in Philadelphia (USA), features five days of educational sessions on scientific, clinical, technical and management challenges facing laboratory professionals, as well as the world’s largest Clinical Lab Expo.
Related Links:
Adhesives Research
American Association for Clinical Chemistry
Latest AACC 2016 News
- Molecular Test Detects Three Arboviruses in Plasma Samples
- Derived Exosomal Protein Biomarkers in Alzheimer’s Disease Diagnosis
- New Biochip Array Developed for ApoE4 Classification
- Cell-Free DNA Identifies Liver Transplant Patients with Acute Rejection
- New Method Tested for Early Diagnosis Pediatric Diabetic Nephropathy
- FDA-Cleared Automated Cell Counter for CSF Launched at AACC 2016
- Semen Analysis Portfolio with Two New Products Featured at AACC 2016
- Automation Solutions for Clinical Diagnostic Equipment Showcased at AACC 2016
- New Tubes Designed for Medium Sample Volumes
- Multi Sample Osmometer Improves Testing Efficiency
- Innovative Information System Optimizes Laboratory Processes
- Innovative eLearning Interface Seamlessly Connects Competency Data
- Cloud-Based Connectivity Platform Advances Decentralized Healthcare
- Point-of-Care Immunoassay Analyzer on Display at AACC Annual Meeting
- Assay for Determination of 17-OH Progesterone to Be Featured at AACC Annual Meeting
- Fully Automated HbA1c Analyzer Available for Inspection at AACC Annual Meeting
Channels
Clinical Chemistry
view channel
Blood Metabolite Test Detects Early Cognitive Decline
Timely identification of individuals at risk of dementia remains difficult because symptoms commonly appear only after significant neurodegeneration. Accessible screening tools that flag subtle cognitive... Read more
AI-Based Blood Test Diagnose Multiple Brain Disorders from Blood Sample
Diagnosing the cause of age-related cognitive symptoms remains challenging because clinical presentations of neurodegenerative diseases often overlap, and multiple pathologies can co-occur... Read moreMolecular Diagnostics
view channel
ctDNA MRD Test Identifies Breast Cancer Patients Who May Avoid Surgery
Selecting surgery versus non-surgical management in early-stage breast cancer can be challenging for older patients, who often balance disease control with comorbidities and quality-of-life considerations.... Read more
WGS MCED Assay Demonstrates Rising Sensitivity and High Specificity
Early detection of cancer remains difficult across many tumor types, and current single‑cancer screening modalities leave significant gaps. Blood‑based, multi‑cancer assays aim to detect tumor signals... Read moreHematology
view channel
Rapid Cartridge-Based Test Aims to Expand Access to Hemoglobin Disorder Diagnosis
Sickle cell disease and beta thalassemia are hemoglobin disorders that often require referral to specialized laboratories for definitive diagnosis, delaying results for patients and clinicians.... Read more
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read moreImmunology
view channel
Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection
Active tuberculosis (TB) remains a leading cause of death and illness worldwide, yet distinguishing contagious disease from latent infection continues to challenge clinicians. Standard screening tools... Read more
FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas
Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Study Identifies Inflammatory Pathway Driving Immunotherapy Resistance in Bladder Cancer
Bladder cancer remains a prevalent malignancy with variable responses to immune checkpoint inhibitors. Clinicians often observe elevated C-reactive protein and interleukin-6 in affected patients, yet the... Read moreMicrobiology
view channel
New Bacterial Target Identified for Early Detection of Noma
Noma is a rapidly progressing orofacial infection that begins as gingivitis and can destroy oral and facial tissues, primarily affecting young children living in extreme poverty. Without treatment, it... Read more
Genomic Analysis Links Emerging Streptococcal Strains to Specific Infections
Streptococcus dysgalactiae subspecies equisimilis (SDSE) infections are increasing worldwide and include variants that may lead to severe disease. Researchers now report that whole-genome sequencing of... Read morePathology
view channel
AI Tool Predicts Patient-Specific Chemotherapy Benefit in Breast Cancer
Selecting adjuvant chemotherapy for early-stage breast cancer is typically guided by recurrence risk and population-level averages rather than patient-specific benefit. However, existing clinicopathologic... Read more
AI-Based Pathology Model Guides Chemotherapy Decisions in Breast Cancer
Selecting adjuvant chemotherapy for early-stage breast cancer remains a difficult decision because only a subset benefits and many undergo toxicity without gain. Genomic assays can help but are costly,... Read moreTechnology
view channel
New AI Tool Enables Rapid Treatment Selection in Pediatric Leukemia
Children with T-cell acute lymphoblastic leukemia face an aggressive disease that remains difficult to treat. Although remission rates have improved, many survivors experience long-term effects from intensive... Read more
Breakthrough Mass Spectrometry Design Could Enable Ultra-Low Abundance Detection
Mass spectrometry is central to identifying and quantifying molecules in complex biological samples, but conventional instruments typically analyze ions sequentially, which can limit detection of rare species.... Read moreIndustry
view channel
Takara Bio USA and Hamilton Partner Partner to Automate NGS Library Preparation
Takara Bio USA, Inc. (San Jose, CA, USA), a wholly owned subsidiary of Takara Bio Inc., and Hamilton Company (Reno, NV, USA) announced a development and co-marketing agreement to deliver integrated, automated... Read more





.jpg)


